We speculate that when γ-synuclein expression is very high, as in many carcinomas, PLCβ2-γ-synuclein may disrupt preformed PLCβ2-Gαq-receptor complexes in the basal state (see [33], [34]) or perturb the cellular localization of the enzyme. Here, PLCB2 is linked to carcinoma.